Recent studies suggest the presence of genetically distinct subtypes of attention deficit/hyperactivity disorder (ADHD) and that attention problems can be treated with receptor subtype selective nicotine agonists. In this study, individuals with two independent familial subtypes of ADHD defined by latent class analysis were systematically screened for sequence variations in the coding regions and intron/exon junctions of the nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4). Common polymorphisms were used for transmission disequilibrium test (TDT) analyses. A significant association was found for a 5 0 intron 2 single nucleotide polymorphism and severe inattention problems (P ¼ 0.007, effect size ¼ 4, 95% CI 1.3-14.1). The location of the polymorphism is compatible with it affecting pre-mRNA stability or splicing.
Recent studies suggest the presence of genetically distinct subtypes of attention deficit/hyperactivity disorder (ADHD) and that attention problems can be treated with receptor subtype selective nicotine agonists. In this study, individuals with two independent familial subtypes of ADHD defined by latent class analysis were systematically screened for sequence variations in the coding regions and intron/exon junctions of the nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4). Common polymorphisms were used for transmission disequilibrium test (TDT) analyses. A significant association was found for a 5 0 intron 2 single nucleotide polymorphism and severe inattention problems (P ¼ 0.007, effect size ¼ 4, 95% CI 1.3-14.1). The location of the polymorphism is compatible with it affecting pre-mRNA stability or splicing. Attention deficit/hyperactivity disorder (ADHD) [1] [2] [3] represents a group of highly heritable syndromes of early onset characterized by problems with attention span, distractibility, impulsivity, and/or the presence of hyperactivity. 11 A variety of recent pharmacological, imaging and neuropsychological studies have suggested that the attention problems manifested in ADHD are due to dysfunctions of ventral catecholaminergic pathways projecting to prefrontal and frontal cortex. 4 Most efforts in identifying genes contributing to ADHD have focused on dopamine pathway genes (eg, LaHoste et al, 5 Cook et al, 6 Comings et al, 7 Daly et al 8 and Faraone et al 9 ). However, these catecholaminergic pathways are also regulated by other neurotransmitter systems such as acetylcholine. For example, stimulation of nicotinic acetylcholine receptors results in increases in dopamine release. 10 Clinical trials with nicotine and nicotine agonists have demonstrated enhancements in attention tasks including improved performance by adults with ADHD. [11] [12] [13] [14] [15] These studies suggest that abnormal modulation of nicotinic acetylcholine pathways may be a contributing factor to inattention problems in ADHD syndromes.
Nicotinic acetylcholine receptors are pentameric protein complexes that form a central core for ion movement. Though many subunit genes are expressed in brain, the two primary subunit complexes appear to be an alpha7 homomeric complex and an alpha4-beta2 heteromeric complex. The attentional effects of nicotine agonists are due to a high affinity complex, such as an alpha4-beta2. 16 Several nicotinic receptor subunits, including the alpha4 subunit, are enriched in catecholamine producing regions in brain, as well as the target regions of ventral projecting catecholaminergic pathways 17, 18 making them candidate genes for mediating the effects of acetylcholine on attention. In this paper, we present the results of systematic mutation screening for sequence variations in coding sequences and adjacent exon/intron junctions of the CHRNA4 gene using denaturing high-performance liquid chromatography (DHPLC). Two groups of individuals who represent independent familial subtypes of ADHD as defined by latent class analysis 1 were screened for the presence of polymorphisms using DHPLC followed by transmission disequilibrium analysis of common variants.
The results of the mutation screening of the amplicons described in Table 1 in these two latent class defined ADHD subtypes are shown in Table 2 . A variety of single nucleotide polymorphisms (SNPs) were found in the regions surrounding and including exons 2, 3, and 5. No evidence of sequence variations was found for amplicons including exons 1, 4, and 6. Since exon 7 contains no coding sequence, it was not included in the survey. Several of the detected SNPs observed in this screen have been previously reported. In contrast, one of the three common polymorphisms of amplicon 2 (SNP3) and two of the four common polymorphisms of amplicon 5 (SNP3 and SNP4) are novel. The seven amplicon 2 and 5 SNPs were genotyped in the parents of a sample of ADHD trios. Haplotypes, created from the SNP data using SIMWALK (V2.6), were analyzed using the ETDT software. The allelewise significance levels for the TDT of these polymorphic haplotypes are displayed in Table 3 for the latent class and DSM-IV defined ADHD subtypes. No significant associations were found for haplotypes of amplicon 5. In contrast, significant associations were found for the amplicon 2 and combined haplotypes for both latent class and DSM-IV defined inattentive ADHD and for any DSM-IV ADHD. TDT analysis of individual amplicon 5 SNPs and haplotypes showed no significant allele associations.
TDT analyses of individual alleles and haplotypes for amplicon 2 SNPs are shown in Table 4 . The locations of the three amplicon 2 SNPs are shown in Fig. 1 . After correcting for multiple comparisons, the only significant SNP association is that of SNP3 of amplicon 2 with latent-class-defined inattentive ADHD. In this case, the G-allele was transmitted 16 out of 20 times (P ¼ 0.007, P 0 (corrected P value) ¼ 0.015, effect size ¼ 4, 95% CI 1.3-14.1). Only three of eight possible haplotypes for the amplicon 2 SNPs were found. When these were used for TDT analyses, a negative association was found with the CGA haplotype showing transmission of the haplotype in only four of 20 informative matings (P ¼ 0.007, P 0 ¼ 0.022). The SNP3 G-allele was divided across the two remaining haplotypes, neither of which had an individually significant TDT value. It should be noted that the frequency of the SNP3 Gallele (91% in parents) resulted in only 20 of 91 severe inattentive problems trios being informative. As expected for a causative or linked polymorphism, given the sample selection strategy, SNP1 and SNP2 were in Hardy-Weinberg equilibrium for parents (n ¼ 359) while SNP3 was not (w 2 ¼ 13.48, P ¼ 0.002). To our knowledge, only two previous studies have looked at the association of ADHD and the CHRNA4 gene. These include the analysis of an intron 1 Cfo1 restriction site polymorphism and DSM-IV defined ADHD 26 and the analysis of an intron 1 dinucleotide repeat polymorphism in a quantitative analysis of DSM-IV defined ADHD. 7 Kent et al 26 found no evidence for association of ADHD with the Cfo1 polymorphism. Comings et al 7 reported a marginally significant association of the intron 1 dinucleotide repeat polymorphism with a quantitative measure of ADHD symptomatology.
As shown in Figure 1 , the intron 2 SNP3 G/A polymorphism is close to the 3 0 exon/intron boundary. This sequence is somewhat unusual in having a large number of GT and AG dinucleotides. Otherwise, the exon/intron structure is unremarkable following the standard AG/GT rule for exon splicing. The 5 0 end of intron 2 contains a standard gtaggtg consensus donor splicing sequence. The structure of this region is similar to that found in other genes that are alternately spliced and is compatible with the SNP3 polymorphism affecting pre-mRNA stability and/or splicing. These possibilities are being pursued.
These results lend support to the de novo mutation screening approach employed here and support the use of these novel classifications of ADHD phenotypes for genetic studies. Though these findings need to be replicated in other samples, the current results suggest that pharmacological trials of alpha4 agonists in the treatment of ADHD, such as recently reported by Wilens et al, 27 should consider targeting individuals with pure attention problems vs those who have combined inattention, hyperactivity, and impulsivity.
Materials and methods
The participants of this study are individuals identified in a birth records-based twin study from the state of Missouri. 19 Families in which the presence of three or more inattentive ADHD symptoms were endorsed as being present by a parent for one or both twins during a brief telephone interview were invited to participate. One parent and both twins were independently interviewed by different interviewers using a DSM-IV version of the Diagnostic Interview for Children and Adolescent (DICA-R) called the MA-GIC. 20 As for most studies, parent : offspring agreement for the presence of DSM-IV ADHD in the offspring was significant but poor (k ¼ 0.26, 95% CI 0.11-0.4). For the purpose of this study, only parental information about the twins was used. Twins were assigned to latent classes based on analysis of the 18 ADHD symptoms reported by the parent (mother 93.5% of the time) as described previously. 1, 21 For the entire epidemiological sample, the prevalence of DSM-IV inattentive and combined ADHD subtypes is 3.8 and 2.7%, respectively, with 2.3 : 1 male-female ratio. The prevalence of latent class defined severe inattention and severe combined ADHD subtypes is 6.5 and 10.0%, respectively, with a 3:1 male-female ratio.
The samples used here represent the first 178 interviewed families in which one twin had a diagnosis of interest and DNA was available for all family members. Females with ADHD are overrepresented in this ongoing study since female : female twin pairs were sampled first. 1 The DHPLC screening sample consisted of 85 individuals in the severe attention problems latent class and 87 individuals in the severe combined problems latent class. The sample for TDT analysis (see below) consisted of 94 trios assigned to the severe inattention problems latent class and 101 trios in which the offspring was assigned to the severe combined latent class (one affected offspring plus both biological parents). Of these trios, 62 contained an offspring with DSM-IV combined subtype ADHD and 87 contained an offspring with DSM-IV primarily inattentive subtype ADHD. The offspring sample was 54.4% male, with an age range of 7-17 years. The parent-reported ethnicity/racial composition was 12.6% African American, 84.4% European American and 3% other. One-third of offspring were monozygotic and twothirds were same or opposite sex dizygotic twins. Only one twin from a monozygotic diagnostically concordant pair was included in the analyses. For dizygotic twins, both could be included if both were in a latent class of interest (n ¼ 16). This is a subset of samples previously used in association studies of ADHD and the dopamine DRD4 receptor gene, 22 the dopamine transporter gene 23 and a mutation screening study of the dopamine DRD2 receptor gene. 24 No significant associations with known or newly detected polymorphisms were found in any of these studies.
Primers were chosen to flank protein coding exons including 20-50 base pairs of surrounding intronic sequence as judged by DNA sequence information from GenBank (access numbers NT_011333.4, X87629, X89721-6, L35901, U62433 and Y08421). Primers and predicted characteristics are summarized in Table 1 . PCR product amplification, DHPLC analysis and confirmation of genomic DNA sequence variation by DNA sequencing have been previously described. 24 Polymorphisms found to be present in at least 10 individuals in one of the two screening populations were also genotyped for transmission disequilibrium test (TDT) analysis. For individuals homozygous by DHPLC analysis (a single elution peak), genotypes were confirmed by mixing amplicons from homozygous samples with known sequence variations, denaturing and repeating the DHPLC. For individuals homozygous with the test sequence, a single DHPLC peak is expected. For individuals different from the test sequence, a complex DHPLC pattern is predicted. 24 All analyses were completed using the ETDT software. 25 For polymorphic markers with more than two alleles, a logistic model performs a global allelewise analysis to test preferential transmission of alleles across all heterozygous parental genotypes. The ETDT also performs the traditional transmission distortion test for each allele. Tables 2-4 ). Underlined sequence represents the primers used for amplification. Sequence is from genomic reference sequence NT-011333.4.
